rabbit polyclonal antibody (Novus Biologicals)
Novus Biologicals is a verified supplier 
Novus Biologicals manufactures this product 
94
Structured Review
Novus Biologicals
rabbit polyclonal antibody
Rabbit Polyclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 105 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+antibody/Survivin+Antibody/us12344642-1044-154-157
Average 94 stars, based on 105 article reviews
Rabbit Polyclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 105 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+anti+survivin+antibody/Survivin+Antibody/us12344642-1044-154-157
Average 94 stars, based on 105 article reviews
rabbit polyclonal antibody - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
other:Article Title: APC/C Cdh1 is required for the termination of chromosomal passenger complex activity upon mitotic exit. Article Snippet: Commercial antibodies used were: mouse monoclonal anti-Aurora A, anti-Aurora B, and anti-p27Kip1 antibodies (#610938, #611082 and #610242, respectively; BD Transduction Laboratories); rabbit polyclonal anti-INCENP (#2786; Cell Signaling Technology); rabbit monoclonal anti-FoxM1 p-T600, anti-HA, anti-Aurora A p-T288/Aurora B p-T232/Aurora C p-T198, and anti-vinculin antibodies (#14655, #3724, #2914 and #13901, respectively; Cell Signaling Technology); anti-Cdc23 and anti-INCENP antibodies (#ab72206 and #ab12183; Abcam); rabbit monoclonal anti-Aurora B (#ab45145; Abcam); mouse monoclonal anti-Cdh1/Fzr and anti-Cdc20 antibodies (#K0085-3 and #K0140-3, respectively; MBL); rabbit polyclonal anti-cyclin A antibody (#sc-751; Santa-Cruz Biotechnology); Article Title: APC/C Cdh1 is required for the termination of chromosomal passenger complex activity upon mitotic exit Article Snippet: Commercial antibodies used were: mouse monoclonal anti-Aurora A, anti-Aurora B, and anti-p27 Kip1 antibodies (#610938, #611082 and #610242, respectively; BD Transduction Laboratories); rabbit polyclonal anti-INCENP (#2786; Cell Signaling Technology); rabbit monoclonal anti-FoxM1 p-T600, anti-HA, anti-Aurora A p-T288/Aurora B p-T232/Aurora C p-T198, and anti-vinculin antibodies (#14655, #3724, #2914 and #13901, respectively; Cell Signaling Technology); anti-Cdc23 and anti-INCENP antibodies (#ab72206 and #ab12183; Abcam); rabbit monoclonal anti-Aurora B (#ab45145; Abcam); mouse monoclonal anti-Cdh1/Fzr and anti-Cdc20 antibodies (#K0085-3 and #K0140-3, respectively; MBL); rabbit polyclonal anti-cyclin A antibody (#sc-751; Santa-Cruz Biotechnology); Transfection:Article Title: Expression and Function of Survivin in Canine Osteosarcoma Article Snippet: Transfected cells were washed, fixed with methanol, and air-dried, followed by incubation in rabbit polyclonal anti-survivin antibody (Novus Biologicals) followed by Alexa Fluor 594 goat anti-rabbit IgG (H þ L; Invitrogen). Article Title: Involvement of α5 integrin in survivin-mediated osteosarcoma metastasis. Article Snippet: The signals were visualized using an enhanced ECL kit from Amersham Pharmacia Biotech. .. Transfected cells were washed, fixed with methanol, and airdried, then incubated with Article Title: Expression and Function of Survivin in Canine Osteosarcoma Article Snippet: Osteosarcoma has a highmortality rate and remains in need ofmore effective therapeutic approaches.. Survivin is an inhibitor of apoptosis familymember protein that blocks apoptosis and drives proliferation in human cancer cells where it is commonly elevated.. In this study, we illustrate the superiority of a canine osteosarcomamodel as a translational tool for evaluating survivin-directed therapies, owing to the striking similarities in gross and microscopic appearance, biologic behavior, gene expression, and signaling pathway alterations. Incubation:Article Title: Expression and Function of Survivin in Canine Osteosarcoma Article Snippet: Transfected cells were washed, fixed with methanol, and air-dried, followed by incubation in rabbit polyclonal anti-survivin antibody (Novus Biologicals) followed by Alexa Fluor 594 goat anti-rabbit IgG (H þ L; Invitrogen). Article Title: Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma. Article Snippet: Canine lymphoma (LSA) and osteosarcoma (OS) have high mortality rates and remain in need of more effective therapeutic approaches.. Survivin, an inhibitor of apoptosis (IAP) family member protein that inhibits apoptosis and drives cell proliferation, is commonly elevated in human and canine cancer.. Survivin expression is a negative prognostic factor in dogs with LSA and OS, and canine LSA and OS cell lines express high levels of survivin. Article Title: Involvement of α5 integrin in survivin-mediated osteosarcoma metastasis. Article Snippet: The signals were visualized using an enhanced ECL kit from Amersham Pharmacia Biotech. .. Transfected cells were washed, fixed with methanol, and airdried, then incubated with Article Title: Expression and Function of Survivin in Canine Osteosarcoma Article Snippet: Osteosarcoma has a highmortality rate and remains in need ofmore effective therapeutic approaches.. Survivin is an inhibitor of apoptosis familymember protein that blocks apoptosis and drives proliferation in human cancer cells where it is commonly elevated.. In this study, we illustrate the superiority of a canine osteosarcomamodel as a translational tool for evaluating survivin-directed therapies, owing to the striking similarities in gross and microscopic appearance, biologic behavior, gene expression, and signaling pathway alterations. Expressing:Article Title: YM155 reverses rapamycin resistance in renal cancer by decreasing survivin. Article Snippet: Renal and renal pelvis tumors make up approximately 3 % of all malignancies.. Most of these cases are renal cell carcinomas (RCC), which are genetically and histologically different from renal pelvis tumors. although approximately 60 % of new cases are diagnosed by coincidence, nearly 25 % are metastatic at the time of diagnosis.. Radical or partial nephrectomy is still the standard therapy in localized RCC. Immunohistochemical staining:Article Title: YM155 reverses rapamycin resistance in renal cancer by decreasing survivin. Article Snippet: Renal and renal pelvis tumors make up approximately 3 % of all malignancies.. Most of these cases are renal cell carcinomas (RCC), which are genetically and histologically different from renal pelvis tumors. although approximately 60 % of new cases are diagnosed by coincidence, nearly 25 % are metastatic at the time of diagnosis.. Radical or partial nephrectomy is still the standard therapy in localized RCC. Staining:Article Title: YM155 reverses rapamycin resistance in renal cancer by decreasing survivin. Article Snippet: Renal and renal pelvis tumors make up approximately 3 % of all malignancies.. Most of these cases are renal cell carcinomas (RCC), which are genetically and histologically different from renal pelvis tumors. although approximately 60 % of new cases are diagnosed by coincidence, nearly 25 % are metastatic at the time of diagnosis.. Radical or partial nephrectomy is still the standard therapy in localized RCC. Labeling:Article Title: YM155 reverses rapamycin resistance in renal cancer by decreasing survivin. Article Snippet: Renal and renal pelvis tumors make up approximately 3 % of all malignancies.. Most of these cases are renal cell carcinomas (RCC), which are genetically and histologically different from renal pelvis tumors. although approximately 60 % of new cases are diagnosed by coincidence, nearly 25 % are metastatic at the time of diagnosis.. Radical or partial nephrectomy is still the standard therapy in localized RCC. |
